Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month

    NEXT STORY
    Vyriad Inc. Announces Development of a New Antibody Test to Determine Protective Immunity From COVID-19
    PREV STORY
    Montreal Heart Institute Colcorona Study receives grant from the COVID-19 Therapeutics Accelerator via the Bill & Melinda Gates Foundation to investigate cheap, readily available drug
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    OpGen Announces New Members to its Clinical Advisory Board

    GAITHERSBURG, Md., March 21, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine ...

    author_avatar
    NASDAQ Market News

    LIDDS continues to grow with new hire to manage pre-clinical trials

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

    author_avatar
    NASDAQ Market News